leisure time -WSS

leisure time

author：comprehensive 2025-09-29 20:52:53 - browse：49

BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning.

A few senior leaders are expected to depart as part of the reorganization. Chief Science Officer Cartier Esham, Chief Public Affairs and Marketing Officer Rich Masters, and Chief Policy Officer John Murphy are expected to leave, four sources said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

hotspot

WSS

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

As demand for Covid shots wanes, Moderna seeks its next success

How Long Island became the ‘eugenics capital of the world’

In Memoriam: Notable people who died in 2023

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to make AI work for medicine

Hollywood unions extend contract negotiations for actors

CDC advisory panel says seniors 'may' get RSV vaccine

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AstraZeneca bets AAV gene therapy will still deliver the goods

Dobbs anniversary: the lost opportunity of abortion as health care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Peter Hotez and the public health issue of online harassment

Walensky prepares to leave CDC — and Congress — behind

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Diversity in medical illustrations gets boost from Chidiebere Ibe

FDA panel gives mixed vote on blood pressure devices

Medical records are filled with copy

Feds fine Medicare Advantage plans for overcharging members

Feds fine Medicare Advantage plans for overcharging members

focus

hotspot

hotspot

explore